Dextroamphetamine Sulfate Capsule, Extended Release
Product Images NDC 45963-304

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Sulfate (NDC 45963-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of dextroamphetamine sulfate, illustrating the molecular formula with two dextroamphetamine groups and one sulfuric acid (H2SO4) component.*

FDA Label Image

Image 10

Label for dextroamphetamine sulfate extended-release capsules, 15 mg strength, from Teva Pharmaceuticals. The label includes directions for pharmacists to dispense the medication guide, notes the package contains 90 capsules, and provides dosing and storage instructions. The National Drug Code (NDC) is 45963-305-09 with a barcode and serialization coding area present.*

FDA Label Image

Image 2

An instructional diagram showing three stepwise illustrated instructions for administering an oral medication capsule. The first image shows a hand holding the capsule, the second image depicts the capsule being swallowed with a glass of water, and the third image shows the capsule in the mouth to be taken orally.*

FDA Label Image

Image 3

FDA Label Image

Image 4

A single dextroamphetamine sulfate extended-release capsule in 10 mg strength. The capsule is half blue and half orange, with no visible imprint or markings. It is an oral dosage form manufactured by Actavis Pharma, Inc.*

FDA Label Image

Image 5

The image shows a single 5 mg extended-release capsule of dextroamphetamine sulfate. The capsule is orange and white, with text printed on the orange half. The product is labeled as a human prescription drug by Actavis Pharma, Inc., intended for oral use.*

FDA Label Image

Image 6

The image shows a white, opaque capsule with blue markings. It is labeled as dextroamphetamine sulfate extended-release capsule, 10 mg strength, manufactured by Actavis Pharma, Inc. The capsule has printed text including the number '10' and the letter 'A' visible on its body.*

FDA Label Image

Image 7

Dextroamphetamine sulfate extended-release capsule label showing 10 mg strength. The capsule is natural and opaque and contains blue and white pellets. Labeler information, Actavis Pharma, Inc., is included on packaging.*

FDA Label Image

Image 8

Label for Dextroamphetamine Sulfate Extended-Release Capsules 5 mg, indicating 90 capsules per container. The label notes prescription-only status, pharmacist dispensing instructions to provide the medication guide, and storage instructions. Manufactured for Teva Pharmaceuticals, Parsippany, NJ.*

FDA Label Image

Image 9

Label of dextroamphetamine sulfate extended-release capsules, 10 mg strength, containing 90 capsules. The label includes instructions to dispense the medication guide to patients, storage conditions, and pharmacist directions. It is manufactured for Teva Pharmaceuticals by Actavis Pharma, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.